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Background: Increased levels of reactive oxygen species during and after surgery may affect inflammatory response,
post-operative adhesion molecule formation, and hemodynamic stability. The glutathione redox cycle is an important
regulator in oxidative stress and its reduced forms scavenge free radicals. N-acetyl cysteine, a precursor of reduced
glutathione, is considered as a potentially therapeutic wide spectrum agent in clinical practice. We therefore examined
whether N-acetyl cysteine improves some biochemical parameters in cancer patients undergoing major abdominal
surgery.
Methods: Thirty-three patients diagnosed with pancreas, stomach, rectum, colon malignancies, and undergoing major
abdominal surgery at Ankara Numune Training and Research Hospital were randomly divided into two groups; control
(CON) and N-acetyl cysteine (NAC). The NAC group had 1,200 mg N-acetyl cysteine starting two days before the
operation day, in addition to isonitrogenous and isocaloric total parenteral nutrition of 1.2 g/kg protein, 25 kcal/kg, and
60:40 carbohydrate/fat ratio. Blood and urine samples were drawn two days before the operation, on operation day,
and on the first, third, and fifth days post-operation.
Results: Plasma malondialdehyde was significantly lower in the NAC group (P < 0.001). N-acetyl cysteine treatment did
not affect plasma levels of vitamin A, C or E. The NAC group exhibited a higher ratio of reduced glutathione to oxidised
glutathione (P = 0.019). Urinary nitrate level was also significantly lower in the NAC group (P = 0.016).
Conclusion: The study demonstrated the clinical importance of N-acetyl cysteine supplementation on antioxidant
parameters in abdominal surgery patients. In these patients N-acetyl cysteine and vitamin administration can be
considered as an effective method for improvement of oxidative status.
Keywords: Major abdominal surgery, N-acetyl cystein, Plasma amino acids, Oxidant parametersIntroduction
Free radicals are important compounds that may affect
progress in trauma, tissue damage, and chronic degenera-
tive diseases [1]. Under normal physiological conditions
these reactive compounds are removed by an organism’s
antioxidant mechanisms [2]. However, lack of balance
between oxidant and antioxidant molecules may trigger
harmful effects of free radicals, especially under sub-
optimal conditions such as cancer [3]. Therefore, reducing
oxidative stress and supporting the antioxidant system are* Correspondence: htbf@hacettepe.edu.tr
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[4,5].
N-acetyl cysteine (NAC) is the N-acetylated form of
amino acid L-cysteine and is used in the first step of
glutathione (GSH) synthesis, by extracting cysteine from
the N-acetylated derivative [6]. Since GSH is the funda-
mental thiol antioxidant of the human body and NAC
provides a rate-limiting cysteine needed for glutathione
synthesis, much work to date has investigated the role of
NAC as an oxidative stress suppressor in various diseases
[7-11]. It was shown that NAC exerts these antioxidant
effects through promoting glutathione synthesis [12]. The
direct free radical chelating property of NAC has also
been examined, although results relating to the reactivityral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have been controversial [13]. In addition to these mecha-
nisms, reduction in leukocyte-endothelium interaction,
oxidative burst of neutrophils, anti-inflammatory, and
mucolytic actions were all associated with NAC [12-14].
Most of the studies that assess the effectiveness of NAC
have focused on cardiac, liver, and abdominal surgery, due
to its protective effects against oxidant stress contributed
by surgical operations. These studies have demonstrated
some beneficial effects of NAC on postoperative atrial
fibrillation, postoperative adhesion formation, ischemia/
reperfusion injury, and peritoneal fibrinolytic activity
[14-17]. However, results have been inconsistent with those
of other trials in which the influence of NAC was exam-
ined [18,19]. Certainly, there is strong evidence to support
the direct effect of NAC on antioxidant capacity of gluta-
thione redox cycle in vitro [12]. Hence, it is of interest
to investigate the effect of NAC treatment on related
biomarkers. For this perspective, the objective of this
study was to examine the effect of NAC treatment on
oxidant, antioxidant, and plasma amino acid levels in
major abdominal surgery patients.
Material and methods
Thirty-three non-smoker oncology patients (18 male
and 15 female) undergoing major abdominal surgery at
Ankara Numune Training and Research Hospital were
included in the study. Patients were diagnosed with pan-
creas cancer (CON, n = 3; NAC, n = 3), stomach cancer
(CON, n = 10; NAC, n = 7), rectum cancer (CON, n = 3;
NAC, n = 4), and colon cancer (CON, n = 1; NAC, n = 2).
The exclusion criteria were as follows: emergency oper-
ation; pregnancy; breast feeding; impaired renal function;
preoperative IV feeding; inability to maintain hemodynamic
conditions that allowed optimal conventional resuscitation;
mean arterial pressure persistently under 70 mm Hg
despite inotropic support; hemotocrit values below 30%
or receiving blood transfusions; unable to keep a PaO2 of
80 to 140 mm Hg and CO2 of 35 to 50 mm Hg or requir-
ing a fractional inspired oxygen concentration (FiO2) of
over 50; severe heart disease; or taking calcium channel
antagonists, angiotensin converting enzyme inhibitors,
corticosteroids, NAC, or other drugs with antioxidant
activity. Patients were randomly divided into two groups:
control (CON) and experimental (NAC) group. All patients
received isonitrogenous and isocaloric total parenteral
nutrition of 1.2 g/kg protein, 25 kcal/kg, and 60:40 carbo-
hydrate/fat ratio. The NAC group was given 1,200 mg
of NAC (300 mg in every 6 h) through total parenteral
nutrition, starting from 2 days before the operation and
lasting until the fifth post-operative day. This dose of
NAC supplementation was considered to be clinically
relevant in order to avoid pro-oxidant effects. Blood
and 24 h urine samples were collected 2 days beforeoperation (baseline), on operation day, and the first,
third and fifth post-operation days. The study protocol
was approved by the Minister of Health Research Ethics
Committee (B100İEG0110011).
Anthropometric measurements
Body weight and body composition of patients were
measured by a Bodystat 1500 (Bodystat Douglas Isle of
Man, UK). In addition to body composition, mid-upper
arm circumference (MUAC) and triceps skinfold thickness
(TSFT) were measured. Nutritional Risk Index (NRI) was
derived as follows: NRI = (1.519 × serum albumin, g/L) +
(41.7 × present/usual body weight). A NRI score of >100
indicates no risk for the patient; 97.5 to 100, mild risk;
83.5 to 97.5, moderate risk; and < 83.5, severe risk.
Blood and urine samples
Pre-operative baseline blood samples were taken after
12 h of starvation. Following two days of NAC supple-
mentation or control treatment, patients were operated.
Operation day blood samples were taken 2 h after surgery.
Post-operation day 1, 3 and 5 blood samples were taken.
Twenty-four hour urine samples were collected on the
same days in sterile containers and stored at -20°C. Blood
samples were centrifuged and stored at -80°C. Plasma
amino acid analyses were performed using a GC amino
acid kit (EZ:faast).
Blood indicators of oxidative stress and antioxidants
Reduced (GSH) and oxidized glutathione (GSSG) were
determined from whole blood samples and malondialde-
hyde (MDA) was analyzed from plasma samples using
high pressure liquid chromatography [20,21]. Similarly,
vitamin C, A, and E were assayed using high pressure
liquid chromatography of plasma samples as previously
described [22,23].
Nitrate and nitrite analysis
Urine nitrate and nitrite was determined using a spectro-
photometer (UNICAM 1500) and read at an absorbance
of 538 nm. Glycine–(NaOH) buffer and copper (CuSO₄)
saturated cadmium were used to reduce nitrate to
nitrite [24].
Statistical analysis
All data were analysed using the Statistical Package for
Social Sciences (version 16; SPSS, Inc., Chicago, IL, USA).
The effect of NAC supplementation on biochemical and
antioxidant parameters was examined using ANOVA with
factors of treatment and time (i.e., the day that the sam-
ples were taken [pre-operation, operation day, and the
first, third, fifth days post-operation]). Tukey’s post hoc
test was performed when the main time effect was signifi-
cant. Values are expressed as mean values with their
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All 33 subjects completed the study successfully. Table 1
shows the characteristics of the two study groups. Age
and anthropometric measurements were similar between
groups, yet BMI and body composition were different
between male and female participants. NRI data indicated
that all of the participants were at risk of malnutrition
(Table 1). This was a mild risk for female participants of
the NAC group, whereas female participants of the con-
trol group and all other male participants exhibited a
moderate risk of malnutrition. Total and post-operative
lengths of stay at hospital were similar between groups
(Table 1).
Plasma amino acid levels
NAC treatment (1,200 mg) resulted in significantly
increased plasma cystine concentration throughout the
study (5.30 ± 2.05 μmol/L, CON versus 14.71 ± 2.08 μmol/
L, NAC, P = 0.002) (Figure 1A). Although there was a trend
towards a rise in plasma cystine concentration during
post-operational days in the NAC group, the effect of day
was not significantly important in either group. Plasma
essential amino acid (EAA) levels was unaffected by NAC
treatment at any stage of the study (398.28 ± 42.87 μmol/L,
CON versus 433.05 ± 43.38 μmol/L, NAC, P > 0.05)
(Figure 1B). However, time exhibited a significant effect
on plasma EAA levels since there was a significant differ-
ence in plasma EAA concentration between the operation
day and post-operational fifth day in both groups
(286.49 ± 68.13 μmol/L, operation day versus 590.33 ±
69.26 μmol/L, post-operational fifth day, P = 0.029). Simi-
larly, branched chain amino acid (BCAA) concentrationTable 1 Characteristics of the two study groups
Control grou
Male (n = 9)
Age (y) 60.44 ± 4.35
BMI (kg/m2)a 20.05 ± 1.03
Body fat (%)a 32.07 ± 2.65
Body water (%)a 55.00 ± 3.98
Fat-free mass (kg)a 38.93 ± 2.30
Triceps skin fold thicknessa 6.93 ± 0.86
Mid upper arm circumference (cm) 22.76 ± 0.84
Nutritional risk index 92.70 ± 3.30
Total length of stay (d) 23.11 ± 3.85
Post-operation length of stay (d) 15.89 ± 6.15
Data presented as mean ± SEM.
aSignificantly different between male and female participants in all groups (P < 0.00was not influenced by NAC treatment, although it exhib-
ited a significant difference between the operation day and
post-operational fifth day (286.49 ± 68.13 μmol/L, oper-
ation day versus 590.33 ± 69.26 μmol/L, post-operational
fifth day, P = 0.046) (Figure 1C). Plasma aromatic amino
acid (AAA) concentration was found to be affected by
both treatment (P < 0.001) and day (P = 0.017) (Figure 1D).
While plasma AAA was significantly higher in the NAC
group than the control group (87.37 ± 6.04 μmol/L, CON
versus 129.77 ± 6.11 μmol/L, NAC, P < 0.001); and was
also significantly lower on operation day when compared
to pre-operational values in both groups (136.71 ±
9.45 μmol/L, pre-operation versus 93.88 ± 9.59 μmol/L,
operation day, P = 0.017).
Oxidant and antioxidant parameters
Oxidant and antioxidant parameters of the two study
groups are shown in Table 2. Plasma MDA exhibited sig-
nificantly lower levels in the NAC group when compared
to controls (0.44 ± 0.01 μmol/L, CON versus 0.36 ±
0.01 μmol/L, NAC, P < 0.001). This effect of NAC on
plasma MDA was independent of the time of sampling,
which suggests that plasma MDA concentration was not
influenced by pre-, post-, or day of operation. A similar
pattern was observed for urinary nitrate levels, which
showed that the NAC group had significantly lower
nitrate concentrations (350.73 ± 31.15 μmol/L, CON versus
242.17 ± 31.91 μmol/L, NAC, P = 0.016), irrespective of the
day. The exception to this was the urinary nitrite level,
which was similar between groups (10.83 ± 1.07 μmol/L,
CON versus 9.30 ± 1.09 μmol/L, NAC, P > 0.05) and was
not affected by sample day (Table 2).
NAC supplementation also had remarkable influence
on the variables associated with glutathione redox cycle
(Figure 2). Although there was a marked decrease in
whole blood GSH levels during post-operation, whenp NAC group
Female (n = 8) Male (n = 9) Female (n = 7)
57.38 ± 3.58 56.56 ± 4.05 65.29 ± 5.49
25.80 ± 1.45 20.99 ± 1.18 25.11 ± 0.79
44.44 ± 3.38 27.60 ± 4.05 42.81 ± 3.2
46.90 ± 2.45 59.30 ± 3.47 48.20 ± 2.45
33.24 ± 2.82 43.44 ± 3.46 35.96 ± 3.87
18.05 ± 1.45 8.27 ± 1.49 18.96 ± 2.07
22.80 ± 0.76 23.43 ± 1.22 23.79 ± 1.08
95.65 ± 3.68 92.41 ± 5.06 98.97 ± 2.55
27.89 ± 3.85 30.88 ± 4.09 23.57 ± 4.37






Figure 1 Data presented as mean ± SEM. CON n = 17, NAC
n = 16. A: Plasma cystine levels. NAC group had significantly higher
plasma cystine levels compared to the control group (P = 0.002). No
significant effect of day was found on plasma cystine level. B: Plasma
EAA levels. Tukey’s post-hoc test showed a significant difference
between operation day and post-operational fifth day on plasma
EAA levels in both study groups (P = 0.029). No significant effect of
treatment was found on plasma EAA. C: Plasma BCAA levels. Tukey’s
post-hoc test showed a significant difference between operation day
and post-operational fifth day on plasma EAA levels in both study
groups (P = 0.046). No significant effect of treatment was found on
plasma BCAA. D: NAC group had significantly higher plasma AAA
when compared to control group (P < 0.001). Tukey’s post-hoc test
showed a significant difference between pre-operation day and
operation day on plasma AAA levels in both study groups (P = 0.017).
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30.99 μmol/L, operation day versus 563.38 ± 30.53 μmol/
L, post-operational third day, P = 0.016), NAC treatment
resulted in significantly increased GSH levels when com-
pared to controls (589.58 ± 24.80 μmol/L, CON versus
671.76 ± 25.30 μmol/L, NAC, P = 0.023). Whilst whole
blood GSH levels increased in the NAC group, GSSG
levels decreased significantly (268.74 ± 17.43 μmol/L,
CON versus 206.07 ± 17.78 μmol/L, NAC, P = 0.014)
and independently of the day (Figure 2). These effects of
NAC treatment on GSH and GSSG levels were reflected
in the GSH:GSSG ratio, which was higher in patients
receiving NAC treatment (2.92 ± 0.88 μmol/L, CON ver-
sus 5.92 ± 0.90 μmol/L, NAC, P = 0.019) (Figure 2).
One of the aims of the present was to assess whether
NAC treatment had any impact upon antioxidant vita-
mins. In this context, plasma vitamin A, C, and E levels
were analyzed. Although oxidant parameters were influ-
enced by NAC treatment from the early phase of the
study, antioxidant vitamins did not exhibit the same trend
(Table 2). Plasma vitamin A levels were significantly
higher during the pre-operational period in both groups
(1.32 ± 0.07 μmol/L, pre-operational day versus 0.82 ±
0.07 μmol/L, operation day, 0.58 ± 0.07 μmol/L, post-
operational first day, 0.64 ± 0.07 μmol/L, post-operational
third day, 0.83 ± 0.07 μmol/L, post-operational fifth day,
P < 0.001). Interestingly, vitamin C level was found to
be significantly lower in the NAC group, irrespective of
the study days (2.59 ± 0.10 mg/L, CON versus 2.11 ±
0.10 mg/L, NAC, P = 0.001) and vitamin E levels were
similar between all groups (Table 2).
Discussion
This study aimed to examine the influence of NAC sup-
plementation on plasma amino acid levels, as well as
antioxidant and oxidant parameters, in cancer patients
undergoing major abdominal surgery. The results demon-
strated that NAC treatment, starting from 2 days before
the operation day and lasting until the post-operational
Table 2 Oxidant and antioxidant parameters
Group Day
Pre-op Op day Post-op 1 Post-op 3 Post-op 5
MDA (μmol/L)* CON 0.45 ± 0.03 0.45 ± 0.03 0.45 ± 0.03 0.44 ± 0.03 0.43 ± 0.03
NAC 0.35 ± 0.03 0.35 ± 0.03 0.37 ± 0.03 0.36 ± 0.03 0.36 ± 0.03
Nitrate (μmol/L)† CON 293.58 ± 69.22 287.16 ± 69.22 262.63 ± 69.22 381.18 ± 69.22 529.09 ± 71.35
NAC 197.44 ± 71.35 211.11 ± 71.35 285.81 ± 71.3 242.49 ± 71.35 274.01 ± 71.35
Nitrite (μmol/L) CON 8.61 ± 2.38 11.28 ± 2.37 9.85 ± 2.37 14.96 ± 2.37 9.45 ± 2.45
NAC 9.39 ± 2.45 8.13 ± 2.45 10.91 ± 2.45 9.83 ± 2.45 8.24 ± 2.45
Vitamin A (μmol/L) CON 1.22 ± 0.09a 0.76 ± 0.09b 0.51 ± 0.09b 0.64 ± 0.09b 0.88 ± 0.09b
NAC 1.43 ± 0.09a 0.89 ± 0.10b 0.64 ± 0.09b 0.64 ± 0.09b 0.77 ± 0.10b
Vitamin C (mg/L)‡ CON 2.66 ± 0.22 2.68 ± 0.23 2.65 ± 0.22 2.48 ± 0.22 2.49 ± 0.24
NAC 2.29 ± 0.23 2.26 ± 0.23 2.07 ± 0.23 1.99 ± 0.23 1.96 ± 0.23
Vitamin E (μmol/L) CON 29.24 ± 1.65 20.54 ± 1.65 16.04 ± 1.65 18.97 ± 1.65 21.22 ± 1.76
NAC 34.86 ± 1.70 21.03 ± 1.70 16.30 ± 1.70 18.20 ± 1.70 20.09 ± 1.70
Data presented as mean ± SEM.
*Plasma malondialdehyde level was influenced by NAC treatment (P < 0.001).
†Urinary nitrate level was influenced by NAC treatment (P = 0.016).
‡Plasma vitamin C level was influenced by NAC treatment (P = 0.001).
a,bMean values with unlike superscript letters in the same row were significantly different (P < 0 · 05).
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stress in these patients. MDA, which is a crucial indicator
of lipid peroxidation, was 18.18% lower in the NAC treated
group when compared to controls. Similarly, nitrate levels,
which can be considered as an oxidative stress biomarker
in urine, decreased 30.95% in the NAC group. Given
that intracellular GSSG accumulates and the GSH:
GSSG ratio decreases under increased levels of oxidative
stress, increased GSH:GSSG ratio implies an improved
cellular oxidative capacity [6]. Here we found that the
GSH:GSSG ratio was 50.68% greater in the NAC group
than controls.
Surgery initiates a wide spectrum of suboptimal alter-
ations in body homeostasis and is closely associated with
several complications of surgical stress, of which exposure
to increased oxidative stress is considered as an important
component [25]. From this perspective, improved antioxi-
dant mechanisms may help to combat oxidative stress.
Although the current study demonstrated diminished
levels of oxidant stress factors, antioxidant factors such as
vitamin A, C, and E did not exhibit improvement. In fact,
vitamin C level was found to be lower in the NAC group.
To date, only a few studies have examined the effects of
NAC and antioxidant vitamins on disease and reported
beneficial effects of these combined therapies [26,27],
however, the principal reason behind the lower or
unaltered levels of these vitamins in the current study
remains unknown. A recent study has shown that NAC
administration during high-intensity exercise did not
change blood glutathione levels but diminished lipid
peroxidation [28], and there is also evidence regarding the
altered pre-operative and post-operative total oxidativestress and total antioxidant capacities following NAC
treatment [29]. Therefore total oxidative stress and total
antioxidant capacities should be measured in future
studies to elucidate the antioxidant mechanisms that
are associated with NAC action. In addition, cancer
patients tend to have lower circulating concentrations
of antioxidant vitamins, either due to altered nutritional
status, increased catabolic processes, or inflammatory
response [30]. Indeed, the current study revealed that
all plasma antioxidant vitamin levels were lower in the
NAC group than in healthy individuals. To further
investigate the clinical relevance of this finding, future
studies should focus on antioxidant vitamin supple-
mentation together with NAC, and seek the oxidant
status of these patients.
NRI is a useful tool for the early identification of nutri-
tional depletion in hospitalised patients [31]. It was consid-
ered that determining the nutritional status of patients
before surgery was needed to address the increased risk of
malnutrition related disorders, and that NRI data reflected
a mild risk of malnutrition in the current study. This
situation emphasizes the importance of pre-operative
care strategies in order to combat malnutrition and
post-operational morbidity and mortality, since these
factors were shown to be related [32]. Since hospital
malnutrition is one of the most important challenges in
clinical practice, novel strategies should be developed
to avoid the progress of malnutrition in cancer patients
undergoing surgery. A study which used NAC infusion
at a rate of 0.3 mg/kg/min intravenously during surgery
and 0.2 mg/kg/min for 24 h during post-operation
showed a significantly shorter period in the intensive
Figure 2 Data presented as mean ± SEM. CON n = 17, NAC n = 16. A: Blood reduced glutathione (GSH) levels. *Indicates the significant effect
of NAC treatment when compared to control group (P = 0.023). **Indicates the significant effect of day. Tukey’s post-hoc test showed a significant
difference between operation day and post-operational third day on blood GSH levels in both study groups (P = 0.016). B: Blood oxidised glutathione
(GSSG) levels. *Indicates the significant effect of NAC treatment when compared to control group (P = 0.014). No significant effect of day was found on
GSSG levels. C: *Indicates the significant effect of NAC treatment when compared to control group (P = 0.019). No significant effect of day was found
on GSH/GSSG ratio.
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high dose oral of NAC was reported to be ineffective
on post-operative hospital stay after heart surgery [18].The current study also did not exhibit a significant
effect on length of stay in hospital. In fact, despite a
non-significant outcome, post- or total length of stay
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reason of this outcome can be attributable to specific
gender differences rather than an experimental effect,
since some studies indicated that gender may play a
deterministic role in duration of length of stay in hospital
[34,35]. Future studies should examine whether these
differences can be attributable to specific responses to the
treatment, preventable complications, or bias. In addition,
the effect of NAC supplementation on hospital care
should be considered in future studies, since NAC may
exert a protective effect through shortening the length of
stay, and lowering malnutrition rate and morbidity in the
post-operative period.
The therapeutic feature of antioxidants relies on their
capacity to cross the cell membranes [12]. When NAC
is administered through oral or intravenous routes, it
undergoes N-deacetylation [12]. There is some conflict-
ing data about the mechanisms of the antioxidant action
of NAC as it has not yet been clearly shown whether the
effectiveness of NAC should be attributed to its direct
involvement in synthesis of intracellular GSH after N-
deacetylation, its ability to reduce extracellular cystine to
cysteine, or its direct chelating property to free radicals
[13]. The current study demonstrated a profound increase
in GSH levels in the NAC treated group, as in other
studies [13,36]. These data clearly indicate the impact
of NAC supplementation on GSH synthesis. However,
the effect of NAC supplementation on cystine to cysteine
reduction is not clear since the cystine data introduced in
this study did not distinguish the reduced cysteine and
cystine. It is known that more than 90% of the total
soluble cysteine in plasma is in the oxidized cystine form
[37]. In another study, in which the kinetics of uptake and
deacetylation of NAC in erythrocytes was investigated,
NAC was found to replace a cysteine with a cystine
molecule and enhance plasma free cysteine levels [38].
The current study exhibited a significant increase in
cystine levels following NAC supplementation, especially
after the operation day. Since the cysteine levels were
undetected, the interpretation of this outcome becomes
complicated. However, when the oxidative milieu of blood
and short half-life of NAC is taken into account, rapid
oxidation of cysteine to cystine should also be considered
[39]. However, it should also be considered that the
amount of available intracellular cysteine is the limiting
factor in GSH synthesis. Therefore, our finding of in-
creased GSH in the NAC treated group may suggest that
the amount of NAC taken was sufficient to induce GSH
synthesis in these patients. Moreover, continuous infusion
of NAC through total parenteral nutrition may help to
reduce the risk of oxidative injury. Further research
should focus on the interactions between NAC and related
biomarkers to reinforce current knowledge about the
mechanisms of NAC.In disease and trauma, adequacy of specific amino acids
becomes an important issue. It is well-known that require-
ments of the amino acids may change under traumatic
conditions [40]. Beyond their common functions, specific
amino acid supplementation in total parenteral nutrition
was shown to induce beneficial effects in operative cancer
patients [41,42]. Therefore, one of the aims of the current
was to determine plasma amino acid levels along with
NAC supplementation. Despite the clear effect of NAC
on plasma cysteine, as discussed above, no major effect
of NAC was found on other plasma amino acid levels.
In fact, operation day appeared to have a greater impact on
plasma amino acid levels. A recent study that investigated
the changes in plasma BCAA and glutamine concentra-
tions in operative gastrointestinal cancer patients indicated
that the fall in BCAA levels were partially prevented by
total parenteral nutrition [43]. Our results did not ex-
hibit such an effect on BCAA, whereas AAA appeared
to remain at higher levels during the treatment. Further
studies investigating the influence of total parenteral
nutrition on plasma protein and amino acid levels in
surgery patients should be performed.
N-acetyl cysteine supplementation was associated with
pro-oxidant effects in experimental models, which caused
concerns about its application in clinical practice when
there is a lack of significant oxidative stress factor [12].
Certainly, the amount of NAC used is the determinative
factor for the pro-oxidant effects. In the current study,
NAC was infused at a rate of 300 mg in every 6 h (i.e.,
1,200 mg/day). This amount is a low to intermediate level
when compared to other studies in the literature [13,18].
In another study, even a low dose of NAC supplementa-
tion, which was 2 to 4 mmol/l in cardioplegia solution,
significantly reduced the MDA levels [44]. In a study in
which the pro-oxidant and deleterious effects of NAC
were shown in healthy individuals, NAC was used up to
2,400 mg over longer periods [45]. Therefore, using
1,200 mg of NAC/day provided a safe and clinically rele-
vant dose which could be considered in further studies
and applications.
This study examined the hypotheses that NAC may
improve oxidant and antioxidant parameters in cancer
patients undergoing major abdominal surgery, and the
data generated supports the assertion that NAC may
provide beneficial effects in these patients. Despite these
improved parameters, it should be taken into account
that the present study has several limitations. One of the
most important limitations is the lack of follow-up of
patients. Monitoring the prognosis of patients and other
physical outcomes would provide a complete understand-
ing of the clinical consequences. Therefore, future studies
should acknowledge the long-term and solid effects of
NAC supplementation on prognosis, recovery, and sur-
vival rates of the patients in addition to the length of
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are needed to generalise the beneficial effects of NAC on
surgery patients. A recent systematic review that aimed to
analyse the effectiveness of pharmacological modulation
of oxidative stress in surgery related interventions of ani-
mal models, reported that NAC was effective at reducing
oxidative stress markers [46]. Although the exact mecha-
nisms of this action remains to be understood completely,
these results indicate the clinical relevance of translating
this approach to human studies. Consequently, supporting
oxidative defence mechanisms in surgery patients should
be evaluated within the limits of ordinary clinical practice,
yet these practices may help to improve normal body
homeostasis in these patients.
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